Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$4.07 - $5.3 $83,435 - $108,650
-20,500 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$4.7 - $7.24 $42,770 - $65,884
-9,100 Reduced 30.74%
20,500 $100,000
Q2 2021

Aug 16, 2021

BUY
$6.81 - $10.93 $201,576 - $323,528
29,600 New
29,600 $202,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.